A. Bachy

发表

Biochemical and electrophysiological properties of SR 57746A, a new, potent 5‐HT1A receptor agonist

P. Soubrié, M. Hamon, R. Steinberg, 1993, Fundamental & clinical pharmacology.

SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.

P. Soubrié, D. Gully, R. Boigegrain, 1999, The Journal of pharmacology and experimental therapeutics.

Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype.

R. Boigegrain, R. Roncucci, M. Arnone, 1983, Life sciences.

Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites.

K. Bizière, M. Morre, P. Keane, 1988, The Journal of pharmacology and experimental therapeutics.

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells.

P Ferrara, P. Soubrié, P. Casellas, 1998, European journal of pharmacology.

SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.

M. Hamon, M. Héaulme, J. Michaud, 1993, European journal of pharmacology.

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.

P. Soubrié, G. Fur, M. Rinaldi-Carmona, 1996, Life sciences.

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

P. Soubrié, D. Gully, R. Boigegrain, 1997, The Journal of pharmacology and experimental therapeutics.

Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells.

F. Gros, J. Vayssière, J. Larcher, 1989, European journal of pharmacology.

Allosteric effects of diprobutine on acetylcholine receptors.

J. Changeux, T. Heidmann, M. Morre, 1985, European journal of pharmacology.

Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells.

J. Herbert, P. Schaeffer, M. Laplace, 2000, European journal of pharmacology.

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.

P. Soubrié, D. Gully, R. Boigegrain, 1997, The Journal of pharmacology and experimental therapeutics.